
Sign up to save your podcasts
Or


Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Slate Podcasts3.9
10531,053 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices

38,053 Listeners

6,795 Listeners

9,231 Listeners

8,475 Listeners

4,008 Listeners

3,533 Listeners

1,022 Listeners

5,626 Listeners

1,864 Listeners

112,075 Listeners

2,356 Listeners

2,071 Listeners

23,910 Listeners

2,127 Listeners

7,228 Listeners

2,404 Listeners

5,831 Listeners

444 Listeners

16,096 Listeners

739 Listeners

1,687 Listeners